News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
725,439 Results
Type
Article (41096)
Company Profile (265)
Press Release (684061)
Multimedia
Podcasts (84)
Webinars (20)
Section
Business (204734)
Career Advice (2026)
Deals (35545)
Drug Delivery (119)
Drug Development (81433)
Employer Resources (173)
FDA (16458)
Job Trends (14960)
News (346571)
Policy (32745)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2583)
Accelerated approval (40)
Adcomms (25)
Allergies (157)
Alliances (49577)
ALS (190)
Alzheimer's disease (1727)
Antibody-drug conjugate (ADC) (357)
Approvals (16759)
Artificial intelligence (582)
Autoimmune disease (213)
Automation (48)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (198)
Biotechnology (174)
Bladder cancer (175)
Brain cancer (62)
Breast cancer (679)
Cancer (5220)
Cardiovascular disease (433)
Career advice (1715)
Career pathing (38)
CAR-T (292)
CDC (52)
Celiac Disease (2)
Cell therapy (786)
Cervical cancer (40)
Clinical research (70079)
Collaboration (1853)
Company closure (4)
Compensation (1245)
Complete response letters (69)
COVID-19 (2723)
CRISPR (98)
C-suite (948)
Cystic fibrosis (145)
Data (6885)
Decentralized trials (3)
Denatured (26)
Depression (149)
Diabetes (542)
Diagnostics (6811)
Digital health (50)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (282)
Drug pricing (191)
Drug shortages (29)
Duchenne muscular dystrophy (265)
Earnings (90898)
Editorial (59)
Employer branding (21)
Employer resources (152)
Events (118189)
Executive appointments (1020)
FDA (19801)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (28)
Funding (1583)
Gene editing (209)
Generative AI (49)
Gene therapy (646)
GLP-1 (1003)
Government (4689)
Grass and pollen (6)
Guidances (394)
Healthcare (18909)
HIV (72)
Huntington's disease (51)
IgA nephropathy (88)
Immunology and inflammation (262)
Immuno-oncology (77)
Indications (153)
Infectious disease (3030)
Inflammatory bowel disease (199)
Inflation Reduction Act (14)
Influenza (126)
Intellectual property (267)
Interviews (316)
IPO (16649)
IRA (50)
Job creations (3645)
Job search strategy (1429)
JPM (58)
Kidney cancer (18)
Labor market (92)
Layoffs (551)
Leadership (34)
Legal (7951)
Liver cancer (94)
Longevity (28)
Lung cancer (699)
Lymphoma (402)
Machine learning (52)
Management (59)
Manufacturing (892)
MASH (174)
Medical device (13833)
Medtech (13909)
Mergers & acquisitions (20035)
Metabolic disorders (1386)
mRNA (170)
Multiple sclerosis (171)
NASH (17)
Neurodegenerative disease (372)
Neuropsychiatric disorders (94)
Neuroscience (3088)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4524)
Now hiring (73)
Obesity (653)
Opinion (273)
Ovarian cancer (179)
Pain (221)
Pancreatic cancer (249)
Parkinson's disease (332)
Partnered (33)
Patents (540)
Patient recruitment (566)
Peanut (60)
People (59160)
Pharmaceutical (60)
Pharmacy benefit managers (31)
Phase 1 (21844)
Phase 2 (30852)
Phase 3 (22978)
Pipeline (6709)
Policy (302)
Postmarket research (2564)
Preclinical (9268)
Press Release (64)
Prostate cancer (270)
Psychedelics (49)
Radiopharmaceuticals (298)
Rare diseases (963)
Real estate (5957)
Recruiting (70)
Regulatory (24848)
Reports (54)
Research institute (2402)
Resumes & cover letters (353)
Rett syndrome (32)
RNA editing (17)
RSV (85)
Schizophrenia (156)
Series A (265)
Series B (196)
Service/supplier (11)
Sickle cell disease (104)
Special edition (22)
Spinal muscular atrophy (160)
Sponsored (44)
Startups (3623)
State (2)
Stomach cancer (18)
Supply chain (116)
Tariffs (84)
The Weekly (56)
Vaccines (1039)
Venture capital (98)
Weight loss (411)
Women's health (108)
Worklife (19)
Date
Today (120)
Last 7 days (597)
Last 30 days (2983)
Last 365 days (29987)
2026 (7170)
2025 (30171)
2024 (35214)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31319)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (737)
Alabama (88)
Alaska (7)
Arizona (327)
Arkansas (13)
Asia (39402)
Australia (6445)
California (12086)
Canada (3462)
China (1195)
Colorado (513)
Connecticut (514)
Delaware (361)
Europe (85080)
Florida (1823)
Georgia (385)
Hawaii (3)
Idaho (61)
Illinois (942)
India (76)
Indiana (551)
Iowa (22)
Japan (473)
Kansas (129)
Kentucky (43)
Louisiana (35)
Maine (73)
Maryland (1470)
Massachusetts (8635)
Michigan (344)
Minnesota (663)
Mississippi (6)
Missouri (136)
Montana (33)
Nebraska (29)
Nevada (132)
New Hampshire (82)
New Jersey (3214)
New Mexico (28)
New York (3172)
North Carolina (1533)
North Dakota (8)
Northern California (5969)
Ohio (359)
Oklahoma (22)
Oregon (41)
Pennsylvania (2442)
Puerto Rico (25)
Rhode Island (50)
South America (1111)
South Carolina (73)
South Dakota (1)
Southern California (4738)
Tennessee (196)
Texas (1885)
United States (42778)
Utah (362)
Vermont (1)
Virginia (287)
Washington D.C. (80)
Washington State (969)
West Virginia (4)
Wisconsin (116)
Wyoming (2)
725,439 Results for "caredx inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 2, 2026
·
1 min read
Press Releases
CareDx to Participate in the Raymond James 47th Annual Institutional Investors Conference
February 18, 2026
·
1 min read
Press Releases
CareDx to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
February 11, 2026
·
1 min read
Press Releases
CareDx to Present AlloHeme™ Pivotal Clinical Validation Data in Hematologic Cancer Relapse Detection at 2026 Tandem Meetings
February 4, 2026
·
4 min read
Press Releases
CareDx Announces Clinical Validation Results for AlloHeme™, the First AI‑Powered NGS Surveillance Solution for AML and MDS Post‑Cell Therapy
February 12, 2026
·
5 min read
Press Releases
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
January 7, 2026
·
7 min read
Press Releases
CareDx to Participate in Upcoming Investor Conferences - November 10, 2025
November 11, 2025
·
1 min read
Press Releases
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - December 26, 2025
December 29, 2025
·
1 min read
Press Releases
CareDx Announces Appointment of Suresh Gunasekaran to Board of Directors
October 22, 2025
·
3 min read
Press Releases
CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025
October 22, 2025
·
1 min read
1 of 72,544
Next
